UK Transparency Hub
← Back

NHS Framework Agreement - London and South of England - Hepatitis C

Awarded by NHS England · 2017-06-08T10:51:25+01:00 · £347,000,000

Description

NHS Framework Agreement for Hepatitis C medicines for London and South of England and interim Hepatitis C Medicines for Midlands & East and North of England Reference - CM/PHR/17/5538/01 - Hepatitis C medicines for London and South of England - 1 September 2017 - 31 August 2018 with an option to extend (at the Authority's discretion) for a period or periods up to 12 months Reference CM/PHR/17/5538/02 - Interim Hepatitis C Medicines for Midlands & East and North of England - 1 September 2017 - 28…

Buyer
NHS England
Value
£347,000,000
Category (CPV)
Pharmaceutical products
Award date
2017-06-08T10:51:25+01:00
Buyer constituency
runcorn-and-helsby

Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.

Loading…
Loading…